<bill session="118" type="hr" number="1039" updated="2024-06-11T16:09:31Z">
  <state datetime="2024-02-29">REFERRED</state>
  <status>
    <introduced datetime="2024-02-29"/>
  </status>
  <introduced datetime="2024-02-29"/>
  <titles>
    <title type="display">Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.</title>
    <title type="official" as="introduced">Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.</title>
  </titles>
  <sponsor bioguide_id="G000583"/>
  <cosponsors>
    <cosponsor bioguide_id="B001298" joined="2024-02-29"/>
  </cosponsors>
  <actions>
    <action datetime="2024-02-29">
      <text>Introduced in House</text>
    </action>
    <action datetime="2024-02-29" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2024-03-08">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2024-05-10T16:58:23Z" status="Introduced in House">This resolution recognizes that Charcot-Marie-Tooth (CMT) disease is significant and expresses the sense that CMT should receive robust funding for research. CMT disease is a neurological disorder that causes damage to the peripheral nerves.</summary>
</bill>
